Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Evangelia Zvintzou

Showing results (1-10 of 20) with videos related to

Pageof 2
Sort By:
Current Atherosclerosis Reports|March 11, 2021
ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering TargetsIoannis Akoumianakis, Evangelia Zvintzou, Kyriakos Kypreos, et al.
Journal of Biomedical Research|November 20, 2019
Pleiotropic effects of apolipoprotein A-Ⅱ on high-density lipoprotein functionality, adipose tissue metabolic activity and plasma glucose homeostasisEvangelia Zvintzou, Eva Xepapadaki, Christina Kalogeropoulou, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|December 14, 2020
Tissue-specific functional interaction between apolipoproteins A1 and E in cold-induced adipose organ mitochondrial energy metabolismEva Xepapadaki, Ioanna Nikdima, Evangelia Zvintzou, et al.
Angiology|June 13, 2019
Τhe Antioxidant Function of HDL in AtherosclerosisEva Xepapadaki, Evangelia Zvintzou, Christina Kalogeropoulou, et al.
Diabetologia|July 13, 2021
HDL and type 2 diabetes: the chicken or the egg?Eva Xepapadaki, Ioanna Nikdima, Eleftheria C Sagiadinou, et al.
Expert Review of Cardiovascular Therapy|March 22, 2014
HDL quality and functionality: what can proteins and genes predict?Eleni A Karavia, Evangelia Zvintzou, Peristera-Ioanna Petropoulou, et al.
Nutrients|January 11, 2025
Effect of a Novel Lavender Extract on Plasma Lipid and Lipoprotein Metabolism, Glucose Tolerance and Adipose Tissue Metabolic Activation: A Preclinical Safety and Efficacy StudyGeorgia Kakafoni, Evangelia Zvintzou, Smaro Kyroglou, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and OpportunitiesEvangelia Zvintzou, Eva Xepapadaki, George Skroubis, et al.
Journal of Biomedical Research|May 18, 2018
Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perceptionKyriakos E Kypreos, Eleni A Karavia, Caterina Constantinou, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 12, 2019
Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in miceEva Xepapadaki, Giuseppe Maulucci, Caterina Constantinou, et al.
Pageof 2

Showing results (1-10 of 20) with videos related to

Sort By:
Pageof 2
Current Atherosclerosis Reports|March 11, 2021
ANGPTL3 and Apolipoprotein C-III as Novel Lipid-Lowering TargetsIoannis Akoumianakis, Evangelia Zvintzou, Kyriakos Kypreos, et al.
Journal of Biomedical Research|November 20, 2019
Pleiotropic effects of apolipoprotein A-Ⅱ on high-density lipoprotein functionality, adipose tissue metabolic activity and plasma glucose homeostasisEvangelia Zvintzou, Eva Xepapadaki, Christina Kalogeropoulou, et al.
Biochimica Et Biophysica Acta. Molecular and Cell Biology of Lipids|December 14, 2020
Tissue-specific functional interaction between apolipoproteins A1 and E in cold-induced adipose organ mitochondrial energy metabolismEva Xepapadaki, Ioanna Nikdima, Evangelia Zvintzou, et al.
Angiology|June 13, 2019
Τhe Antioxidant Function of HDL in AtherosclerosisEva Xepapadaki, Evangelia Zvintzou, Christina Kalogeropoulou, et al.
Diabetologia|July 13, 2021
HDL and type 2 diabetes: the chicken or the egg?Eva Xepapadaki, Ioanna Nikdima, Eleftheria C Sagiadinou, et al.
Expert Review of Cardiovascular Therapy|March 22, 2014
HDL quality and functionality: what can proteins and genes predict?Eleni A Karavia, Evangelia Zvintzou, Peristera-Ioanna Petropoulou, et al.
Nutrients|January 11, 2025
Effect of a Novel Lavender Extract on Plasma Lipid and Lipoprotein Metabolism, Glucose Tolerance and Adipose Tissue Metabolic Activation: A Preclinical Safety and Efficacy StudyGeorgia Kakafoni, Evangelia Zvintzou, Smaro Kyroglou, et al.
Pharmaceuticals (Basel, Switzerland)|June 28, 2023
High-Density Lipoprotein in Metabolic Disorders and Beyond: An Exciting New World Full of Challenges and OpportunitiesEvangelia Zvintzou, Eva Xepapadaki, George Skroubis, et al.
Journal of Biomedical Research|May 18, 2018
Apolipoprotein E in diet-induced obesity: a paradigm shift from conventional perceptionKyriakos E Kypreos, Eleni A Karavia, Caterina Constantinou, et al.
Biochimica Et Biophysica Acta. Molecular Basis of Disease|February 12, 2019
Impact of apolipoprotein A1- or lecithin:cholesterol acyltransferase-deficiency on white adipose tissue metabolic activity and glucose homeostasis in miceEva Xepapadaki, Giuseppe Maulucci, Caterina Constantinou, et al.
Pageof 2